regeneron pharmaceuticals market cap 2012

On December 31, 2012, Regeneron Pharmaceuticals (REGN) had a market capitalization of $19.9B, based on 117.24M shares at a price of $170.13.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
December 31 2012
$170.13
488,100
117,237,000
$19,945,108,756.80
December 28 2012
$167.04
484,300
117,237,000
$19,583,678,809.50
December 27 2012
$167.84
750,400
117,237,000
$19,676,952,566.70
December 26 2012
$169.07
567,000
117,237,000
$19,821,529,235.10
December 24 2012
$172.09
378,400
117,237,000
$20,174,799,487.20
December 21 2012
$172.52
3,872,100
117,237,000
$20,226,102,398.40
December 20 2012
$171.89
837,600
117,237,000
$20,151,481,047.90
December 19 2012
$174.68
804,400
117,237,000
$20,479,099,844.40
December 18 2012
$179.03
695,000
117,237,000
$20,988,600,122.70
December 17 2012
$178.41
927,300
117,237,000
$20,916,311,788.50
December 14 2012
$178.72
424,700
117,237,000
$20,952,455,955.60
December 13 2012
$178.05
890,400
117,237,000
$20,874,340,942.50
December 12 2012
$182.03
554,000
117,237,000
$21,340,698,004.80
December 11 2012
$183.58
557,800
117,237,000
$21,522,579,486.60
December 10 2012
$183.67
470,100
117,237,000
$21,533,072,198.10
December 07 2012
$179.87
627,900
117,237,000
$21,087,700,558.80
December 06 2012
$180.80
801,600
117,237,000
$21,196,133,060.10
December 05 2012
$184.18
903,900
117,237,000
$21,592,534,804.50
December 04 2012
$179.70
627,500
117,237,000
$21,067,875,782.10
December 03 2012
$179.70
910,400
117,237,000
$21,067,875,782.10
November 30 2012
$175.58
2,335,300
117,237,000
$20,584,026,959.40
November 29 2012
$186.70
1,848,100
117,237,000
$21,888,675,466.50
November 28 2012
$173.95
425,300
117,237,000
$20,392,825,136.10
November 27 2012
$173.74
887,000
117,237,000
$20,368,334,326.80
November 26 2012
$173.43
816,600
117,237,000
$20,332,190,159.70
Unlock 2x data

Related Searches